This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
zacks-consensus-estimate: Archive
How Much Upside is Left in Klarna (KLAR)? Wall Street Analysts Think 51.12%
by Zacks Equity Research
The consensus price target hints at a 51.1% upside potential for Klarna (KLAR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Predict a 57.59% Upside in Oddity Tech (ODD): Here's What You Should Know
by Zacks Equity Research
The mean of analysts' price targets for Oddity Tech (ODD) points to a 57.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe Nuvation Bio (NUVB) Could Rally 25.14%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 25.1% upside potential for Nuvation Bio (NUVB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Lamb Weston (LW) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Lamb Weston (LW) delivered earnings and revenue surprises of +2.99% and +1.60%, respectively, for the quarter ended November 2025. Do the numbers hold clues to what lies ahead for the stock?
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Paychex (PAYX) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Paychex (PAYX) delivered earnings and revenue surprises of +1.61% and +0.22%, respectively, for the quarter ended November 2025. Do the numbers hold clues to what lies ahead for the stock?
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Why GE HealthCare Technologies (GEHC) is a Top Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
earnings-estimates growth-investing zacks-consensus-estimate zacks-rank
Oncobiologics, Inc. (OTLK) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Oncobiologics (OTLK) delivered earnings and revenue surprises of +4.35% and -101.50%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Why CBRE Group (CBRE) is a Top Stock for the Long-Term
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
earnings-estimates growth-investing zacks-consensus-estimate zacks-rank
Conagra Brands (CAG) Tops Q2 Earnings Estimates
by Zacks Equity Research
Conagra Brands (CAG) delivered earnings and revenue surprises of +2.27% and -0.35%, respectively, for the quarter ended November 2025. Do the numbers hold clues to what lies ahead for the stock?
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Winnebago Industries (WGO) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Winnebago (WGO) delivered earnings and revenue surprises of +216.67% and +11.32%, respectively, for the quarter ended November 2025. Do the numbers hold clues to what lies ahead for the stock?
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank